High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort

by Bayigga, Lois, Nabatanzi, Rose, Sekiziyivu, Prossy Naluyima, Mayanja-Kizza, Harriet, Kamya, Moses R, Kambugu, Andrew, Olobo, Joseph, Kiragga, Agnes, Kirimunda, Sam, Joloba, Moses, Nakanjako, Damalie
Published 2014

Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial

by Nakanjako, Damalie, Ssinabulya, Isaac, Nabatanzi, Rose, Bayigga, Lois, Kiragga, Agnes, Joloba, Moses, Kaleebu, Pontiano, Kambugu, Andrew D., Kamya, Moses R., Sekaly, Rafick, Elliott, Alison, Mayanja-Kizza, Harriet
Published 2015